Pivekimab
Catalog No.
BA6019
Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).
Featured Products
Pivekimab targets interleukin 3. Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).
Physical Appearance | A liquid |
Storage | -20°C |
Cas No. | 2234335-84-1 |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |